61597-96-4

Usage

Uses

Used in Pharmaceutical Industry:
(+)-Isobutyl D-lactate is used as a chiral building block for the synthesis of various pharmaceutical compounds. Its chirality allows for the creation of enantiomerically pure drugs, which can have different effects and safety profiles compared to their racemic counterparts.
Used in Biodegradable Materials Production:
(+)-Isobutyl D-lactate is used as a monomer in the production of biodegradable materials, particularly poly(lactic acid). This polymer is utilized in packaging materials, textiles, and biomedical devices, offering an environmentally friendly alternative to traditional plastics. It is less harmful to the environment as it breaks down into water and carbon dioxide, reducing the impact of waste on ecosystems.

InChI:InChI=1/C7H14O3/c1-5(2)4-10-7(9)6(3)8/h5-6,8H,4H2,1-3H3/t6-/m1/s1

Upstream product

• 78-83-1 2-methyl-propan-1-ol 
• 13051-48-4 iso-butyl pyruvate 

Downstream Products

• 69122-46-9 (R)-2-bromo-propionic acid isobutyl ester; isobutyl ester of/the/ d-α-bromo-propionic acid 
• 84681-87-8 (-)-α-n-butyryloxy-propionic acid isobutyl ester 
• 103-50-4 dibenzyl ether 
• 121408-94-4 (R)-(+)-isobutyl O-benzyllactate 
• 2051-96-9 benzyl (R)-Lactate 
• 10326-41-7 D-Lactic acid 
• 159572-27-7 (R)-2-((benzyloxy)methoxy)propanal 
• 1171817-31-4 C₃₁H₂₉ClF₃NO₅ 
• 208339-22-4 N-(3,4-dichlorophenyl)-L-alanine iso-butyl ester 
• 4254-14-2 (2R)-propane-1,2-diol 
• 62108-67-2 isobutyl l-2-chloropropionate 
• 668455-68-3 C₁₄H₁₉ClO₃ 
• 1097839-43-4 isobutyl (2S)-2-[3-(bromomethyl)phenoxy]propanoate 
• 103954-20-7 (2S,1'S)-N-<1-(Isobutoxycarbonyl)ethyl>phenylalanin-methylester 

Relevant academic research and scientific papers

Enantioselective hydrogenation of pyruvates over polymer-stabilized and supported platinum nanoclusters

The cinchonidine-modified enantioselective hydrogenation of pyruvates has been studied over polyvinylpyrrolidone-stabilized platinum (PVP-Pt) and the corresponding alumina-supported platinum (Al2O3-Pt) clusters. It is shown that the catalysts with particle size less than 2.0 nm demonstrate >90% enantioselectivity in favor of (R)-lactates. The solvent effect is similar to that over the conventional supported platinum catalyst except for tetrahydrofuran. These colloidal and supported clusters are stable with no obvious loss of activity and enantioselectivity even after 18 months standing in air at room temperature. Molecular mechanics calculations of the modifier- reactant interaction on the platinum surface suggest that it is possible to obtain good enantioselectivity on the small clusters.